Source link : https://newshealth.biz/health-news/dupilumab-linked-to-higher-psoriasis-risk-in-ad/
TOPLINE: Treating atopic dermatitis (AD) with dupilumab vs other systemic agents increased the risk of developing psoriasis over 3 years, a cohort study found. METHODOLOGY: Addressing postmarketing reports of psoriasis in patients treated with dupilumab for AD, researchers conducted a population-based retrospective cohort study of 214,430 adults with AD from the TriNetX Global Collaborative Network, […]
The post Dupilumab Linked to Higher Psoriasis Risk in AD first appeared on News Health.
—-
Author : News Health
Publish date : 2025-06-19 04:24:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8